Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer
PHASE1RecruitingINTERVENTIONAL
Enrollment
10
Participants
Timeline
Start Date
March 20, 2025
Primary Completion Date
July 1, 2026
Study Completion Date
July 1, 2027
Conditions
Colorectal Adenocarcinoma
Interventions
DRUG
Fluoxetine
Receive PO
Trial Locations (1)
90095
RECRUITING
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
All Listed Sponsors
lead
Jonsson Comprehensive Cancer Center
OTHER
NCT06225011 - Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer | Biotech Hunter | Biotech Hunter